Morgan Stanley Maintains Equal-Weight on Outset Medical, Lowers Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Drew Ranieri has maintained an Equal-Weight rating on Outset Medical (NASDAQ:OM) and lowered the price target from $23 to $22.

August 04, 2023 | 1:43 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Outset Medical's price target has been lowered from $23 to $22 by Morgan Stanley, while maintaining an Equal-Weight rating.
The lowering of the price target by a prominent financial institution like Morgan Stanley could potentially lead to a decrease in the stock price of Outset Medical in the short term. The maintained Equal-Weight rating indicates that the stock is expected to perform in line with the sector or the market, which does not provide a strong buy or sell signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100